{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:17:55Z","timestamp":1762928275566,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.respe.2014.03.001","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T21:00:32Z","timestamp":1400101232000},"page":"195-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact de la modification d\u2019avis du Haut Conseil de la sant\u00e9 publique (HCSP) sur le taux de prescription des vaccins papillomavirus humains en r\u00e9gion Midi-Pyr\u00e9n\u00e9es"],"prefix":"10.1016","volume":"62","author":[{"given":"J.","family":"Birebent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dupouy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lemp\u00e9gnat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bourrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bismuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Oustric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"160","key":"10.1016\/j.respe.2014.03.001_bib0005","article-title":"Cancer incidence in five Continents","volume":"9","author":"Curado","year":"2007","journal-title":"IARC Sci Pub"},{"year":"2005","series-title":"Preventing chronic diseases: a vital investment","author":"World Health Organization","key":"10.1016\/j.respe.2014.03.001_bib0010"},{"issue":"3","key":"10.1016\/j.respe.2014.03.001_bib0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.respe.2008.03.117","article-title":"Cancer incidence and mortality in France over the period 1980-2005","volume":"56","author":"Belot","year":"2008","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"5","key":"10.1016\/j.respe.2014.03.001_bib0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1\u00a0virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"issue":"9580","key":"10.1016\/j.respe.2014.03.001_bib0025","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1\u00a0virus-like-particle vaccine against infection with human papillomavirus types 16\u00a0and 18\u00a0in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.respe.2014.03.001_bib0030","unstructured":"Haut Conseil Sant\u00e9 Publique HCSP. Avis du Comit\u00e9 technique des vaccinations et du Conseil sup\u00e9rieur d\u2019hygi\u00e8ne publique de France relatif \u00e0 la vaccination contre les papillomavirus humains par un vaccin bivalent. 14 d\u00e9cembre 2007. Disponible sur http:\/\/www.hcsp.fr\/hcspi\/docspdf\/avisrapports\/hcspa20071214_Papillomavirus.pdf"},{"year":"2007","series-title":"Commission de transparence","author":"Haute Autorit\u00e9 de sant\u00e9","key":"10.1016\/j.respe.2014.03.001_bib0035"},{"year":"2008","series-title":"Commission de transparence","author":"Haute Autorit\u00e9 de sant\u00e9","key":"10.1016\/j.respe.2014.03.001_bib0040"},{"issue":"1","key":"10.1016\/j.respe.2014.03.001_bib0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18\u00a0AS04-adjuvanted vaccine against grade 3\u00a0or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.respe.2014.03.001_bib0050","unstructured":"Avis du Haut Conseil de la sant\u00e9 publique relatif \u00e0 la vaccination contre les infections \u00e0 papillomavirus humains des jeunes filles de 14\u00a0\u00e0 23ans. 17 d\u00e9cembre 2010. Disponible sur http:\/\/www.hcsp.fr\/docspdf\/avisrapports\/hcspa20101217_ppmvjf1423.pdf"},{"issue":"2","key":"10.1016\/j.respe.2014.03.001_bib0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/03630241003705094","article-title":"Factors related to physicians\u2019 willingness to vaccinate girls against HPV: the importance of subjective norms and perceived behavioral control","volume":"50","author":"Askelson","year":"2010","journal-title":"Women Health"},{"key":"10.1016\/j.respe.2014.03.001_bib0060","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0140-6736(93)92244-N","article-title":"Effect of clinical guidelines on medical practice: a systematic review of rigourous evaluations","volume":"342","author":"Grimshaw","year":"1993","journal-title":"Lancet"},{"year":"2012","series-title":"Opinions et pratiques des m\u00e9decins g\u00e9n\u00e9ralistes de l\u2019Yonne (89) \u00e0 propos de la vaccination antipapillomavirus","author":"Hincelin","key":"10.1016\/j.respe.2014.03.001_bib0065"},{"issue":"4","key":"10.1016\/j.respe.2014.03.001_bib0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3406\/sosan.1990.1178","article-title":"Attitudes professionnelles et diffusion de la connaissance scientifique\u00a0: les conf\u00e9rences de consensus sont-elles susceptibles de modifier les comportements des praticiens\u00a0?","volume":"8","author":"Weill","year":"1990","journal-title":"Sci Soc Sante"},{"year":"2009","series-title":"Le comportement des m\u00e9decins g\u00e9n\u00e9ralistes vis-\u00e0-vis du Gardasil\u00ae r\u00e9sulte-t-il d\u2019un choix \u00e9clair\u00e9\u00a0? Enqu\u00eate aupr\u00e8s de 518\u00a0m\u00e9decins g\u00e9n\u00e9ralistes du Rh\u00f4ne","author":"Roddier-Herlant","key":"10.1016\/j.respe.2014.03.001_bib0075"},{"key":"10.1016\/j.respe.2014.03.001_bib0080","first-page":"31","article-title":"La formation m\u00e9dicale continue\u2013quelques donn\u00e9es sur la situation actuelle","volume":"32","author":"Gallois","year":"2000","journal-title":"Actual Dossier Sante Publique HCSP"},{"year":"2007","series-title":"L\u2019information des m\u00e9decins g\u00e9n\u00e9ralistes sur le m\u00e9dicament. Rapport IGAS no\u00a0RM 2007-136P","author":"Bras","key":"10.1016\/j.respe.2014.03.001_bib0085"},{"issue":"26","key":"10.1016\/j.respe.2014.03.001_bib0090","first-page":"383","article-title":"R\u00e9daction prescrire, 15ans d\u2019observation et un constat\u00a0: rien \u00e0 attendre de la visite m\u00e9dicale pour mieux, soigner","volume":"272","year":"2006","journal-title":"Rev Prescrire"},{"year":"2010","series-title":"Estimation des couvertures vaccinales en secteur lib\u00e9ral \u00e0 travers l\u2019\u00e9chantillon g\u00e9n\u00e9raliste des b\u00e9n\u00e9ficiaires en France 2004\u20132009","author":"Fonteneau","key":"10.1016\/j.respe.2014.03.001_bib0095"},{"key":"10.1016\/j.respe.2014.03.001_bib0100","unstructured":"Avis du Haut Conseil de la sant\u00e9 publique relatif \u00e0 la r\u00e9vision de l\u2019\u00e2ge de la vaccination contre les infections \u00e0 papillomavirus humains des jeunes filles. 28 septembre 2012. Consultable sur http:\/\/www.hcsp.fr\/explore.cgi\/avisrapportsdomaine?clefr=302"},{"year":"2012","series-title":"La diffusion du vaccin antipapillomavirus a-t-elle modifi\u00e9 la prise en charge des adolescentes en m\u00e9decine g\u00e9n\u00e9rale","author":"Murat Nazli","key":"10.1016\/j.respe.2014.03.001_bib0105"},{"issue":"32","key":"10.1016\/j.respe.2014.03.001_bib0110","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1016\/j.vaccine.2011.05.006","article-title":"Human papillomavirus vaccination: perception and practice among French general practitioners in the year since licensing","volume":"29","author":"Lutringer-Magnin","year":"2011","journal-title":"Vaccine"}],"container-title":["Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398762014001953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398762014001953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:37:00Z","timestamp":1759970220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0398762014001953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0398762014001953"],"URL":"https:\/\/doi.org\/10.1016\/j.respe.2014.03.001","relation":{},"ISSN":["0398-7620"],"issn-type":[{"type":"print","value":"0398-7620"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact de la modification d\u2019avis du Haut Conseil de la sant\u00e9 publique (HCSP) sur le taux de prescription des vaccins papillomavirus humains en r\u00e9gion Midi-Pyr\u00e9n\u00e9es","name":"articletitle","label":"Article Title"},{"value":"Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.respe.2014.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}